Markets Courses Calendar News Analysis & Opinion Brokers Advertise

Loading

Loading…

Learn to Lead.

Trading-education courses, live markets, financial news, the economic calendar and broker reviews — in one trusted hub.

Learn

All Courses
Forex
Stocks
Crypto

Markets

Indices
Financial News
Economic Calendar
Analysis & Opinion
Broker Reviews

Account

Log in
Sign up
My Learning
About Us
Contact Us
Advertise

Legal

Terms & Conditions
Privacy Policy
Refund & Cancellation
Risk Disclaimer
Cookie Policy

© 2026 Academiya. All rights reserved.

Terms Privacy Refund Risk Disclaimer Cookies

Risk warning: Trading and investing carry risk of loss. Educational content on Academiya is for learning purposes only and is not financial advice. Market data may be delayed.

Markets today

Financial news

The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.

Updated 16 Jun, 07:07 pm

NASDAQ:SYREfmp·15 Jun

BTIG Analyst Raises Price Target for Spyre Therapeutics (NASDAQ:SYRE) to $112 Amid Positive Clinical Trial Results

BTIG has significantly raised its price target for Spyre Therapeutics to $112 , indicating a potential 34% upside for investors. Spyre's experimental drug, SPY002, achieved its primary and secondary endpoints in a Phase 2 trial for inflammatory bowel disease, demonstrating signif

NASDAQ:PDDfmp·15 Jun

PDD Holdings Inc. (NASDAQ: PDD) Faces Headwinds: Underperform Rating, Legal Challenges, and Market Scrutiny

PDD Holdings Inc. (NASDAQ: PDD) received an "Underperform" rating from Exane BNP Paribas, indicating a potential for lower returns compared to the overall market. The company is currently under a securities fraud investigation by Glancy Prongay & Murray LLP, raising significant r

NYSE:KMXfmp·15 Jun

CarMax, Inc. (NYSE: KMX) Q1 Earnings Preview: Key Financials and Market Outlook

Anticipated Earnings Decline: Analysts project a significant year-over-year decrease in both earnings per share (EPS) and revenue for the upcoming quarter. Valuation Metrics: The company currently holds a trailing price-to-earnings (P/E) ratio of 31.09 and a price-to-sales ratio

AMEX:RGNTfmp·15 Jun

Market Movers: Key Company Announcements Fuel Significant Stock Gains

Regentis Biomaterials Ltd. surged over 500% on news of European surgeon training for its GelrinC® product, targeting a significant U.S. market. Horizon Quantum Holdings Ltd. and Cuprina Holdings experienced substantial gains, driven by quantum computing expansion and regainin

NASDAQ:LFVNfmp·15 Jun

Top Stock Losers: Company-Specific Events Drive Market Declines

A merger investigation significantly impacted Fox Corporation's stock performance. Unusual options trading activity led to a steep decline for LifeVantage Corporation. Concerns surrounding pre-IPO investment strategies contributed to the fall of Fundrise Growth Tech Fund, LLC. To

NASDAQ:ROKUfmp·15 Jun

Roku (NASDAQ: ROKU) Acquisition by Fox Corporation: Downgrade and Investor Scrutiny

Roku (NASDAQ: ROKU) is currently the target of a significant acquisition by Fox Corporation, aiming to reshape the television industry landscape. Analyst firm KeyBanc downgraded Roku's stock from "Overweight" to "Sector Weight," reflecting a less bullish outlook on the company's

NYSE:JBLfmp·15 Jun

Jabil (NYSE: JBL) Prepares for Q3 Earnings Amidst AI and Healthcare Growth

Jabil is strategically positioned in high-growth sectors like AI infrastructure and healthcare , expanding its partnerships in advanced technologies. The company is set to release its quarterly earnings report on June 17, 2026, with analysts estimating an EPS of $3.09 and revenue

NASDAQ:STOKfmp·15 Jun

Analyzing Capital Efficiency: Stoke Therapeutics, Inc. (NASDAQ: STOK) Outperforms Biopharma Peers in ROIC/WACC

Stoke Therapeutics' capital efficiency is assessed by comparing its Return on Invested Capital (ROIC) to its Weighted Average Cost of Capital (WACC). Despite a negative ROIC, common for clinical-stage biopharma companies, Stoke Therapeutics' ROIC/WACC ratio stands at -4.63 . Stok

NASDAQ:TRIPfmp·15 Jun

Analyst Raises Price Target for TripAdvisor (NASDAQ:TRIP) Following Strategic Sale

D.A. Davidson analyst increased TripAdvisor's price target to $15.50 from $10.50 , indicating a potential upside of approximately 18.41% . The positive outlook stems from TripAdvisor's strategic sale of its restaurant booking platform, TheFork, to American Express for $700 millio

NASDAQ:FOXAfmp·15 Jun

Fox Corporation (NASDAQ: FOXA) Faces Market Headwinds Following Roku Acquisition Announcement

An analyst from Barclays lowered their price target on Fox Corporation (NASDAQ: FOXA), reflecting a more cautious investment outlook . Investors reacted negatively to Fox Corporation's plan to acquire Roku Inc. (NASDAQ: ROKU) , primarily due to concerns over new debt and potentia

NASDAQ:TSLAfmp·15 Jun

Tesla (NASDAQ: TSLA) Navigates Market Headwinds and Regulatory Scrutiny

Market Headwinds: Tesla faces significant challenges including slowing deliveries and intense pricing wars, leading to skepticism about its future growth trajectory. Ambitious Project Risks: The company's ambitious ventures like robotaxis and AI, including the Optimus robot, are

NASDAQ:CODAfmp·15 Jun

Coda Octopus Group, Inc. (NASDAQ:CODA) Navigates Revenue Dip with Strong Profitability and Strategic Growth

Coda Octopus Group, Inc. exceeded analyst earnings per share estimates despite a miss on quarterly revenue. A significant decline in its Marine Tech Business, influenced by geopolitical instability, was mitigated by strong growth in its defense engineering and precision acoustics

NYSE:VSTfmp·15 Jun

Vistra Corp. (NYSE: VST) Powers Up: AI Demand Fuels Growth and Investor Optimism

Vistra Corp. is strategically positioned to capitalize on the surging demand for electricity, largely driven by the artificial intelligence (AI) boom. Analysts have set ambitious price targets for Vistra Corp., signaling substantial potential upside for investors. The company dem

NASDAQ:CGCfmp·15 Jun

Canopy Growth (NASDAQ: CGC) Navigates Cannabis Market with Restructuring and Strategic Growth

Canopy Growth is actively restructuring its business through cost reductions and strategic acquisitions, such as MTL Cannabis, to enhance its financial position and drive growth in the competitive cannabis industry. For Q4 2026, the company reported an earnings per share of -$0.2

NYSE:KMIfmp·15 Jun

Kinder Morgan (NYSE: KMI) Stock Outlook: Growth and Stability in the Energy Sector

Kinder Morgan maintains a robust position in North American energy infrastructure with a resilient fee-based business model. An analyst from UBS has set a new price target of $43.00 , indicating a potential upside of approximately 36.7% . The company is poised for growth, driven

NYSE:CRMfmp·15 Jun

Salesforce (NYSE: CRM) Bolsters AI Strategy with Fin Acquisition

Salesforce (NYSE: CRM) , a leader in cloud-based software , is actively expanding its artificial intelligence capabilities through strategic acquisitions. Analyst firm Wolfe Research has reaffirmed an "Outperform" rating for Salesforce, signaling strong analyst confidence in the

NASDAQ:AIOTfmp·15 Jun

PowerFleet (NASDAQ: AIOT) Q4 Earnings: Revenue Beats, Net Loss Improves Amid Strategic Turnaround

Revenue Growth: PowerFleet exceeded revenue estimates, showing an 11% year-over-year increase, driven by strong services revenue. Operational Turnaround: Despite an EPS miss, the company significantly improved its net loss and achieved positive income from operations, indicating

NYSE:INVHfmp·15 Jun

Invitation Homes (INVH): Leading Single-Family Rental REIT

Invitation Homes (NYSE: INVH): A Leading Single-Family Rental REIT with Positive Outlook Invitation Homes (NYSE: INVH) is the largest single-family rental company in the U.S., holding a significant position within the REIT sector. Analysts maintain a positive outlook, with BMO Ca

1…444546…49

From Investing.com

Dolphin entertainment CEO William O’Dowd IV buys $4,884 in sharesInvesting.com22m ago
Alphabet VP Marsida Saraci sells $149,606 in class C stockInvesting.com22m ago
Jerry Baack, Bridgewater Bancshares CEO, sells $567,764 in sharesInvesting.com22m ago
NVE Corp president & CEO Baker sells $2.3m in sharesInvesting.com22m ago
Form 4 McEwen Inc. For: 29 JulyInvesting.com23m ago
Form 4 Finwise Bancorp For: 29 JulyInvesting.com23m ago
Form 4 Finwise Bancorp For: 29 JulyInvesting.com23m ago
Form 4 Electronic Arts Inc For: 29 JulyInvesting.com23m ago
Form 4 Biofrontera Inc For: 29 JulyInvesting.com23m ago
Form 4 Finwise Bancorp For: 29 JulyInvesting.com23m ago

Headlines provided by Investing.com

Go deeper

Turn headlines into edge

General
LEARN TO TRADE LIKE A PRO Master Institutional Trading
$2505.0
General
LEARN TO TRADE LIKE A PRO(R) Master Institutional Trading
$150

Browse all courses